| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00625054 |
| P698 | PubMed publication ID | 6604058 |
| P2093 | author name string | R C Marcove | |
| S Groshen | |||
| J M Lane | |||
| G Rosen | |||
| A G Huvos | |||
| A Nirenberg | |||
| A Cacavio | |||
| B I Caparros | |||
| P2860 | cites work | Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy | Q39340821 |
| Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma | Q39465516 | ||
| Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery | Q39553218 | ||
| From wild fowl to stalking horses: Alchemy in chemotherapy.Fifth annual David A. Karnofsky memorial lecture | Q39920504 | ||
| The therapy of osteogenic sarcoma: Current status and thoughts for the future | Q39921246 | ||
| Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases | Q40024188 | ||
| En bloc resection for osteogenic sarcoma | Q40511362 | ||
| Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the Southwest Oncology Group Studies | Q40524499 | ||
| Treatment of osteogenic sarcoma. II. Aggressive resection of pulmonary metastases | Q40599775 | ||
| Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma.Pre-surgical treatment of primary tumor and of overt pulmonary metastases | Q40640605 | ||
| Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity | Q40640612 | ||
| High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity | Q40653373 | ||
| Chemotherapy and thoractomy for metastatic osteogenic sarcoma.A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery | Q40673591 | ||
| Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation | Q40714513 | ||
| cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma | Q40876948 | ||
| Adjuvant treatment with adriamycin in primary operable osteosarcoma | Q40876978 | ||
| Adjuvant chemotherapy for osteogenic sarcoma | Q40876982 | ||
| Study of Adjuvant Chemotherapy in Osteogenic Sarcoma | Q41528608 | ||
| Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue | Q42261724 | ||
| Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma | Q44103159 | ||
| Osteogenic sarcoma in childhood | Q45080767 | ||
| High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma | Q54091788 | ||
| High-dose methotrexate, not a conventional treatment | Q66876759 | ||
| En bloc upper humeral interscapulo-thoracic resection. The Tikhoff-Linberg procedure | Q67052158 | ||
| Recent advances in the chemotherapy of metastatic osteogenic sarcoma | Q69102684 | ||
| Evaluation of chemotherapy in children with metastatic Ewing's sarcoma and osteogenic sarcoma | Q71069990 | ||
| Treatment of osteosarcomata of the distal femur by rotation-plasty | Q72027276 | ||
| High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma | Q72075807 | ||
| Osteogenic sarcoma. A follow-up study of the ninety-four cases observed at the Massachusetts General Hospital from 1920 to 1960 | Q76496317 | ||
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 55-67 | |
| P577 | publication date | 1983-01-01 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy | |
| P478 | volume | 106 Suppl |
| Q44090756 | 18F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma |
| Q36342282 | A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma |
| Q35722935 | Aseptic loosening rates in distal femoral endoprostheses: does stem size matter? |
| Q80510573 | Biology and therapy of malignant solid tumors in childhood |
| Q72331601 | Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? |
| Q70501174 | Chemotherapeutic effect on osteosarcoma on basis of collagen analysis: a proposal of the induction of osteosarcoma differentiation |
| Q45800041 | Combination of 18F-FDG PET/CT and Diffusion-Weighted MR Imaging as a Predictor of Histologic Response to Neoadjuvant Chemotherapy: Preliminary Results in Osteosarcoma |
| Q58739772 | Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma |
| Q34116434 | Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma |
| Q68764684 | Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol |
| Q37239485 | Cytotoxic agents are detrimental to bone formed by distraction osteogenesis |
| Q37279172 | Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study |
| Q53074113 | Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI. |
| Q37635533 | Emerging roles for long noncoding RNAs in skeletal biology and disease |
| Q67705174 | Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents |
| Q77305644 | Limb Lengthening After Limb Sparing for Osteogenic Sarcoma of the Proximal Humerus |
| Q36157313 | Limb salvage in the skeletally immature patient |
| Q35858934 | Local Recurrence has only a Small Effect on Survival in High-risk Extremity Osteosarcoma |
| Q69844842 | Local therapy of rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma of children and adolescents |
| Q34588488 | Long-Term Survivals of Stage IIB Osteosarcoma: A 20-Year Experience in a Single Institution |
| Q36673874 | Long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas. |
| Q34638659 | Long‐term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high‐grade, operable osteosarcoma |
| Q57299081 | Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma |
| Q34476910 | MFH of bone and osteosarcoma show similar survival and chemosensitivity |
| Q72027269 | Magnetic resonance relaxation times of normal tissue in the course of chemotherapy: a study in patients with bone sarcoma |
| Q37180881 | Metastatic osteosarcoma: a review of current issues in systemic treatment |
| Q68760943 | Morphology of pulmonary metastases from osteosarcoma during chemotherapy |
| Q79309728 | Multicentric osteosarcoma with long-term survival |
| Q74618613 | Multidisciplinary Management of Osteosarcoma: Experience in Hong Kong |
| Q67674507 | Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri |
| Q41495156 | Osteogenic sarcoma of the jaws: factors influencing prognosis |
| Q73671887 | Osteosarcoma |
| Q33614621 | Osteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcome |
| Q85232855 | Pasteurized autograft–prosthesis composite for proximal femoral reconstruction: an alternative to allograft composite |
| Q35848126 | Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review |
| Q39768346 | Pharmacokinetics of anticancer drugs in children |
| Q53026369 | Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT. |
| Q68192386 | Primary childhood osteosarcoma: The role of salvage surgery |
| Q68502121 | Proceedings of The British Institute of Radiology Radiology '88 46th Annual Congress, held in Glasgow, May 23–25, 1988 |
| Q93131504 | Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients |
| Q45184508 | Prognostic Value of Tc-99m-MIBI Performed During Middle Course of Preoperative Chemotherapy in Patients With Malignant Bone and Soft-Tissue Tumors |
| Q33592170 | Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma |
| Q71735383 | Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma |
| Q37688620 | Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance |
| Q81631582 | Relationships between plain-film radiographic patterns and clinicopathologic variables in AJCC stage II osteosarcoma |
| Q28080727 | Species differences in tumour responses to cancer chemotherapy |
| Q67726432 | Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience |
| Q33860309 | The Metastasectomy and Timing of Pulmonary Metastases on the Outcome of Osteosarcoma Patients |
| Q44689255 | The angiographic response of osteosarcoma following pre-operative chemotherapy |
| Q40878110 | The role of nuclear medicine in primary bone and soft tissue tumors |
| Q37336486 | The survival of osteosarcoma patients 10 years old or younger is not worse than the survival of older patients: a retrospective analysis |
| Q51774540 | The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient |
| Q44220304 | Treatment of Osteosarcoma 1972-1997: An American Perspective |
| Q53183263 | Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy |
| Q83165217 | Tumor Volume Increase During Preoperative Chemotherapy as a Novel Predictor of Local Recurrence in Extremity Osteosarcoma |
| Q37471417 | miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma. |
Search more.